218 results
Page 3 of 11
8-K
EX-99.1
sdbtv
28 Feb 22
Cassava Sciences Reports Full-year 2021 Financial Results and Operating Updates
12:00am
8-K
EX-99.1
l0rxsyuame9ibh
10 Nov 21
Cassava Sciences Reports Third Quarter 2021 Financial Results
9:10am
8-K
EX-99.2
b3oxet7g87kd388
3 Aug 21
Regulation FD Disclosure
4:36pm
8-K
EX-99.1
8bf660
3 Aug 21
Regulation FD Disclosure
4:36pm
8-K
EX-99.3
q7dqr6s84 plqa
3 Aug 21
Regulation FD Disclosure
4:36pm
8-K
EX-99.1
qnfc1
3 Aug 21
Cassava Sciences Reports Second Quarter 2021 Financial Results
8:45am
8-K
EX-99.1
rd3ud
21 Jun 21
Entry into a Material Definitive Agreement
4:46pm
8-K
EX-99.1
2chtc5o4ej4os5f
14 Jun 21
Cassava Sciences Announces the Appointment of
4:14pm
8-K
EX-99.1
v1f48kix
21 Apr 21
Cassava Sciences Reports First Quarter 2021 Financial Results and Announces Guidance on Clinical Data Release
8:45am
8-K
EX-10.1
c2d4i
12 Feb 21
Cassava Sciences Announces $200 Million Registered Direct Offering of Common Stock
5:09pm
424B5
nbcfs
12 Feb 21
Prospectus supplement for primary offering
12:00am